Skip to main content

Halozyme Therapeutic (NQ: HALO )

55.10 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 16, 2024 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
June 22, 2009
Form 424B5
Source: SEC/Edgar
June 21, 2009
Form 8-K
Source: SEC/Edgar
June 16, 2009
Form 8-K
Source: SEC/Edgar
May 07, 2009
Form 8-K
Source: SEC/Edgar
April 14, 2009
Form DEF 14A
Source: SEC/Edgar
April 01, 2009
Form 8-K
Source: SEC/Edgar
March 12, 2009
Form 8-K
Source: SEC/Edgar
February 08, 2009
Form SC 13G/A
Source: SEC/Edgar
January 29, 2009
Form 8-K
Source: SEC/Edgar
January 25, 2009
Form 8-K
Source: SEC/Edgar
January 08, 2009
Form EFFECT
Source: SEC/Edgar
January 07, 2009
Form CT ORDER
Source: SEC/Edgar
January 04, 2009
Form S-3
Source: SEC/Edgar
November 27, 2008
Form 8-K
Source: SEC/Edgar
November 06, 2008
Form 8-K
Source: SEC/Edgar
November 05, 2008
Form EFFECT
Source: SEC/Edgar
September 28, 2008
Form EFFECT
Source: SEC/Edgar
September 28, 2008
Form EFFECT
Source: SEC/Edgar
September 28, 2008
Form POS AM
Source: SEC/Edgar
September 18, 2008
Form POS AM
Source: SEC/Edgar
September 18, 2008
Form S-8 POS
Source: SEC/Edgar
September 18, 2008
Form POS AM
Source: SEC/Edgar
September 18, 2008
Form S-8 POS
Source: SEC/Edgar
September 18, 2008
Form 8-K
Source: SEC/Edgar
August 20, 2008
Form 8-K
Source: SEC/Edgar
August 07, 2008
Form S-8
Source: SEC/Edgar
August 07, 2008
Form SC 13D/A
Source: SEC/Edgar
July 01, 2008
Form 8-K
Source: SEC/Edgar
May 14, 2008
Form 8-K
Source: SEC/Edgar
May 08, 2008
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.